Vistagen Provides Corporate Update and Reports Fiscal 2024 Second Quarter Financial Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Fasedienol (PH94B) PALISADE Phase 3 Program for acute treatment of social anxiety disorder (SAD) advancing to build on recent positive PALISADE-2 Phase 3 results Preparations to initiate potential fasedienol
TUESDAY, Oct. 17, 2023 (HealthDay News) Solriamfetol seems to be effective for management of attention-deficit/hyperactivity disorder (ADHD) in adults, according to a study published online Oct. 9 in the Journal of Clinical Psychiatry. Craig B. H. Surman, M.D., from Massachusetts General Hospital in Boston, and colleagues performed a remotely conducted, randomized, double-blind, six-week dose-optimization